Pfizer Inc and its German partner BioNTech sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years...
Swiss firm Ferring Pharmaceuticals plans to invest an additional Rs 500 crore in expanding the manufacturing of gastrointestinal (GI) drugs in India over the next three years. The company has pumped Rs 500 crore into an active pharmaceutical...
Drug firm Lupin on Thursday said it has received approval from the US health regulator to market a generic non-steroidal anti-inflammatory drug in the American market. The company has received approval from the US Food and Drug Administration for...
Cell and gene therapies are going to be catalysts of paradigm shifts in the global healthcare arena. Both cell and gene therapies are overlapping fields having similar therapeutic objectives. And it targets DNA or RNA outside the body and both th...
BridgeBio Pharma along with Sentynl Therapeutics has received marketing authorisation from the European Commission for a medication to treat a rare disease, according to a joint statement issued on Tuesday. The companies have received approval for...
The U.S. Food and Drug Administration has approved Fennec Pharmaceuticals Inc's intravenous therapy to prevent chemotherapy-induced hearing loss in children, according to the health regulator's website...
Centrum marks its entry in India under Haleon (erstwhile GlaxoSmithKline Consumer Healthcare). The company announced the launch of Centrum Multivitamin range recognising the difference in nutritional requirements by gender and age in India and...
Aragen Life Sciences Private Limited announced that it has entered into an agreement with UK-based firm, NeoVac, for manufacturing a lipid product that will support the development of lipid nanoparticles (LNP) for use in developing RNA vaccines...
The Tata Memorial Hospital (TMH) operating model will be replicated by the Kalyan Singh Super Specialty Cancer Institute (KSSSCI) in Mumbai. The effort is to learn the TMH model of functioning so that it can be replicated at KSSSCI. The director a...
Since the COVID-19 pandemic first impacted the life science industry around the world, Pharmaceutical R&D spending has reached over $200 billion each year — and it’s projected to surpass $250 billion by 2026. Rising expenditure patterns indicate
, CDSCO.jpg)
